Liminal BioSciences Inc (LMNL) Stock
LMNL is no longer traded. Liminal BioSciences was delisted from the Nasdaq in September 2023.
Prices on this page are historical; the last trade was September 25, 2023 at $8.50.
Liminal BioSciences stock price history
LMNL final trading statistics
- Final close
- $8.50
- Final trading day
- Sep 25, 2023
- Market cap at delisting
- $27.62M
- Shares outstanding
- 3.25M
- Final 52-week range
- $0.31 – $8.50
- Avg. volume (final 3 mo.)
- 23,720
- All-time high (split-adj.)
- $1000000.00 · Dec 2010
- All-time low (split-adj.)
- $3.25 · Dec 2022
- Return since IPO
- -100.0%
- Beta
- 29.34
- Book value / share
- $6.61
- Price / book
- 1.29
Liminal BioSciences annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2022 | $401.0K | -$28.9M | -$2.95 |
| FY2021 | $643.0K | -$45.1M | $6.80 |
| FY2020 | $3.32M | -$122.1M | -$26.06 |
| FY2019 | $4.90M | -$234.2M | $67.25 |
| FY2018 | $47.37M | -$195.4M | -$155.13 |
Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.
About Liminal BioSciences Inc
Liminal BioSciences Inc., a development stage biopharmaceutical company, focuses on the development of novel small molecule drug therapeutics for inflammatory, fibrotic, and metabolic diseases in Canada and the United Kingdom. The company is developing LMNL6511, a selective antagonist for the G-protein coupled receptor 84, is expected to commence a Phase 1 clinical trial. It is also developing potential OXER1 antagonists and GPR40 agonists, which are in preclinical stage. The company was formerly known as Prometic Life Sciences Inc. and changed its name to Liminal BioSciences Inc. in October 2019. Liminal BioSciences Inc. was incorporated in 1994 and is headquartered in Laval, Canada.
Liminal BioSciences stock FAQ
What happened to Liminal BioSciences stock?
Liminal BioSciences stock was delisted from the Nasdaq. Its final close was $8.50 on September 25, 2023.
Is LMNL stock still trading?
No. LMNL was delisted from the Nasdaq in September 2023 and no longer trades on a U.S. exchange.
What was the last price of LMNL stock?
LMNL closed at $8.50 on its final trading day, September 25, 2023, for a market value of about $27.62M.
What were Liminal BioSciences's revenue and earnings in its last full fiscal year?
Liminal BioSciences reported revenue of $401.0K and net income of -$28.9M in fiscal 2022, its last full year as a public company.
When did Liminal BioSciences go public?
Liminal BioSciences Inc stock began trading on November 18, 2019.